FEMASYS INC (FEMY) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US31447E1055
FEMASYS INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.29 m USD |
| Gross profit | 1.42 m USD |
| Operating income | -17.59 m USD |
| EBIT | -16.84 m USD |
| Net income | -18.63 m USD |
| Diluted EPS – continuing operations | -0.47 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About FEMASYS INC
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
More stocks
- BioCardia, Inc. (BCDA)
- Ascent Solar Technologies, Inc. (ASTI)
- BARNWELL INDUSTRIES INC (BRN)
- SPAR Group, Inc. (SGRP)
- Tempus AI, Inc. (TEM)
- M2i Global, Inc. (MTWO)
- Nomadar Corp. (NOMA)
- URBAN ONE, INC. (UONE)
- Fabric.AI, Inc. (FABC)
- AIR INDUSTRIES GROUP (AIRI)
- IRIDEX CORP (IRIX)
- BIOVIE INC. (BIVI)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.